Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancerSally Claridge(NewYork–Presbyterian Hospital), Benjamin D. Hopkins(Cornell University)Clinical and Translational MedicineJanuary 24, 202510.1002/ctm2.70078Cited by 3SaveCiteExport RISWatch citationsRelated PapersAn atlas of substrate specificities for the human serine/threonine kinome|Nature|2023|720Suppression of insulin feedback enhances the efficacy of PI3K inhibitors|Nature|2018|706